High expression of somatostatin receptor subtype 2 (sst2) in medulloblastoma: Implications for diagnosis and therapy

Pediatric Research

Volumn 45, Issue 5, 1999, Pages 697-708

  Frühwald, Michael C ^a,b   O’dorisio, M Sue ^a   Pietsch, Torsten ^c   Reubi, Jean Claude ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; RECEPTOR SUBTYPE; SOMATOSTATIN 14; SOMATOSTATIN RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; AUTORADIOGRAPHY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE RECEPTOR INTERACTION; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MEDULLOBLASTOMA; NEWBORN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; SCHOOL CHILD;

ADOLESCENT; ADULT; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDULLOBLASTOMA; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0344759112     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/00006450-199905010-00016     Document Type: Article

References (77)

1. Rorke LB, Trojanowski JQ, Lee VM-Y, Zimmerman RA, Sutton LN, Biegel JA, Goldwein JW, Packer RJ 1997 Primitive neuroectodermal tumors of the central nervous system. Brain Pathol 7:765-784
2. Yachnis AT 1997 Neuropathology of pediatric brain tumors. Semin Pediatr Neurol 4:282-291
3. Heideman RL, Packer RJ, Albright LA, Freeman CR, Rorke LB 1997 Tumors of the central nervous system. In: Pizzo PA, Poplack DG (eds) Principles and Practice of Pediatric Oncology. Lippincott-Raven, Philadelphia, pp 633-697
4. Schaper A 1897 Die frühesten Differenzierungsvorgänge im Zentralnervensystem. Arch Entwicklungs Mech, Wilhelm Engelmann Verlag, Leipzig, Germany, pp 81-132
5. Raaf J, Kernohan JW 1944 Relation of abnormal collections of cells in posterior medullary velum of cerebellum to origin of medulloblastoma. Arch Neurol Psychiatry 52:163-169
6. Hart NM, Earle KM 1973 Primitive neuroectodermal tumors of the brain in children. Cancer 32:890-897
7. Burnett ME, White EC, Sih S, von Haken MS, Cogen PH 1997 Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the CNS. Cancer Genet Cytogenet 97:25-31
8. Kovar H 1998 Ewing's sarcoma and peripheral primitive neuroectodermal tumors after their genetic union. Curr Opin Oncol 10:334-342
9. Grier HE 1997 The Ewing family of tumors: Ewing's sarcoma and primitive neuroectodermal tumors. Pediatr Clin North Am 44:991-1004
10. Reubi JC, Lang W, Maurer R, Koper J, Lamberts S 1987 Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res 47:5758-5764
11. Qualman SJ, O'Dorisio MS, Fleshman DJ, Labanowski J, Shimada H, O'Dorisio TM 1992 Neuroblastoma: correlation of neuropeptide expression in tumor tissue with other prognostic factors. Cancer 70:2005-2012
12. Gould VE, Jansson DS, Molenaar WM, Rorke LB, Trojanowski JQ, Lee VMY, Packer RJ, Franke WW 1990 Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins. Lab Invest 62:498-509
13. O'Dorisio MS, Fleshman DJ, Qualman SJ, O'Dorisio TM 1992 Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma. Regul Pept 37:213-226
14. Giangaspero F, Burger PC, Budwit DA, Usellini L, Mancini AM 1985 Regulatory peptides in neuronal neoplasms of the central nervous system. Clin Neuropathol 4:111-115
15. Bateman DE, McDermott JR, Perry RH, Dimaline R, Biggins JA, Edwardson JA 1986 Neuropeptides in gliomas: identification of somatostatin 14 in a medulloblastoma. J Neurol Neurosurg Psych 49:1074-1076
16. Leroux P, Bodenant C, Bologna E, Gonzalez B, Vaudry H 1995 Transient expression of somatostatin receptors in the brain during development. In: Chadwick DJ, Cardew G (eds) Somatostatin and Its Receptors. Wiley, Chichester, pp 127-141
17. Patel YC, Greenwood MT, Papetta R, Demchyshyn L, Niznik H, Srikant CB 1995 Mini review: the somatostatin receptor family. Life Sci 57:1249-1265
18. Laquerriere A, Leroux P, Gonzalez B, Bodenant C, Taylor J, Vaudry H 1992 Somatostatin receptors in the human cerebellum during development. Brain Res 573:251-257
19. Pollak M, Schally A 1998 Mechanisms of antineoplastic action of somatostatin analogs. Proc Soc Exp Biol Med 217:143-152
20. Fisher WE, Muscarella P, O'Dorisio TM, O'Dorisio MS, Kim JA, Sabourin CL, Schirmer WJ, Doran TA 1996 Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide. Surgery 120:234-241
21. Weckbecker G, Tolcsvai L, Stolz B, Pollak M, Bruns C 1994 Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7:12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Cancer Res 54:6334-6337
22. O'Dorisio MS, Chen F, O'Dorisio TM, Wray D, Qualman S 1994 Characterization of somatostatin receptors on human neuroblastoma tumors. Cell Growth Differ 5:1-8
23. Rauly I, Saint-Laurent N, Delesque N, Buscail L, Esteve J-P, Vaysse N, Susini C 1996 Induction of negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells. J Clin Invest 97:1874-1883
24. Delesque N, Buscail L, Esteve J-P, Saint-Laurent N, Weckbecker G, Bruns C, Vaysse N, Susini C 1997 sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells. Cancer Res 57:956-962
25. El-Badry OM, Helman LJ, Chatten J, Steinberg SM, Evans AE, Israel MA 1991 Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J Clin Invest 87:648-657
26. Ohmura E, Okada M, Onoda N, Kamiya Y, Murakami H, Tsushima T, Shizume K 1990 Insulin-like growth factor I and transforming growth factor α as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res 50:103-107
27. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M 1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396
28. Sharma K, Srikant P 1996 Subtype specific induction of wild type p53 and apoptosis, but not cell cycle arrest by human somatostatin receptor 3. Mol Endocrinol 10:1688-1696
29. Lamberts SWJ, Krenning EP, Reubi JC 1991 The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 12:240-481
30. O'Dorisio MS, Qualman SJ 1993 Neuroblastoma. In: Mazzaferri EL, Samaan NA (eds) Endocrine Tumors. Blackwell Scientific Publications, Inc., Cambridge, pp 443-456
31. Moertel CL, Reubi JC, Scheithauer BS, Schaid DJ, Kvols LK 1994 Expression of somatostatin receptors in childhood neuroblastoma. Am J Clin Pathol 102:752-756
32. Frühwald MC, O'Dorisio MS, Cottingham SL, Qualman SJ, O'Dorisio TM 1998 Neuropeptides in developmental tumors of the central and peripheral nervous system. Ann N Y Acad Sci 1998;865:420-426
33. Müller HL, Frühwald MC, Scheubeck M, Rendl J, Warmuth-Metz M, Sörensen N, Kühl J, Reubi JC 1998 A possible role for somatostatin receptor (sstr) scintigraphy in the follow-up of children with medulloblastoma (MB). J Neurooncol 38:27-45
34. O'Dorisio MS, Hauger MA, Cecalupo AJ 1994 Somatostatin receptors in neuroblastoma: diagnostic and therapeutic implications. Semin Oncol 21:33-37
35. Martinez DA, O'Dorisio MS, O'Dorisio TM, Qualman SJ, Caniano DA, Teich S, Besner GE, King DR 1995 Intraoperative detection and resection of occult neuroblastoma: a technique exploiting somatostatin receptor expression. J Pediatr Surg 30:1580-1589
36. Jacobsen PF, Jenkyn DJ, Papadimitriou JM 1985 Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J Neuropathol Exp Neurol 44:472-485
37. Friedman HS, Burger PC, Bigner SH, Trojanowski JQ, Wikstrand CJ, Halperin EC, Bigner DD, Jacobsen PF, Jenkyn DJ, Papadimitriou JM 1985 Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 med. J Neuropathol Exp Neurol 44:592-605
38. Friedman HS, Burger PC, Bigner SH, Trojanowski JQ, Brodeur GM, Wikstrand CJ, Kurtzberg J, Berens ME, Halperin EC, Bigner DD 1988 Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 med) demonstrating amplification. Am J Pathol 130:472-484
39. Pietsch T, Scharmann T, fonatsch C, Schmidt D, Oeckler R, Freihoff D, Albrecht S, Wiestler OD, Zeltzer P, Riehm H 1994 Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Cancer Res 54:3278-3287
40. Baker DL, Reddy UR, Pleasure S, Hardy M, Williams M, Tartaglione M, Biegel JA, Emanuel BS, LoPresti P, Kreider B, Trojanowski JQ, Evans A, Roy AR, Ventakatakrishnan G, Chen J, Ross AH, Pleasure D 1990 Human central nervous system primitive neuroectodermal tumor expressing nerve growth factor receptors: CHP707 m. Ann Neurol 28:136-145
41. Chen TR 1977 In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res 104:255-262
42. Sambrook J, Fritsch EF, Maniatis T 1989 Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York, pp 9.31-9.62
43. Wang J, Baltimore D 1983 Cellular RNA homologous to the Abelson murine leukemia virus transforming gene: expression and relationship to the viral sequence. Mol Cell Biol 3:773-779
44. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurements with a folin phenol reagent. J Biol Chem 193:265-275
45. McPherson GA 1985 Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC. J Pharmacol Meth 14:213-228
46. Motulsky. GraphPad Prism 1995GraphPad Prism[2.0]. 1995 San Diego, CA, GraphPad Software, Inc. 1994
47. Reubi JC, Waser B, Laissue JA, Gebbers J-O 1996 Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification. Cancer Res 56:1922-1931
48. Pietsch T, Kyas U, Steffens U, Yakisan E, Hadam MR, Ludwig WD, Zsebo K, Welte K 1992 Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other growth factors. Blood 80:1199-1206
49. Fisher WE, Doran TA, Muscarella P, Boros LG, Allison EC, Schirmer WJ 1998 Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer. J Natl Cancer Inst 90:322-324
50. Coy DH, Murphy WA, Raynor K, Reisine T 1993 The new pharmacology of somatostatin and its multiple receptors. J Pediatr Endocrinol 6:205-209
51. Bruns C, Raulf F, Hoyer D, Schloos J, Lubbert H, Weckbecker G 1996 Binding properties of somatostatin receptor subtypes. Metabolism 45:17-20
52. Reubi JC, Lang W, Mauer R, Koper JW, Lamberts SWJ 1987 Distribution and biochemical characterization of somatostatin receptors in tumors of the central nervous system. Cancer Res 47:5758-5764
53. Lopez F, Esteve J-P, Buscail L, Delesque N, Saint-Laurent N, Theveniau M, Nahmias C, Vaysse N, Susini C 1997 The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling. J Biol Chem 272:24448-24454
54. Reubi JC 1997 Regulatory peptide receptors as molecular targets for cancer diagnosis and therapy. J Nucl Med 41:63-70
55. Albers AR, O'Dorisio MS 1996 Clinical use of somatostatin analogues in paediatric oncology. Digestion 57:38-41
56. Ottle A, Mueller-Brand J, Dellas S, Nitzsche EU, Herman R, Maecke HR 1998 Yttrium-90-labelled somatostatin-analogue for cancer treatment. Lancet 351:417-418
57. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716-731
58. Kogner P, Borgstrom P, Bjellerup P, Schilling FH, Refai E, Jonsson C, Dominici C, Wassberg E, Bihl H, Jacobsson H, Theodorsson E, Hassan M 1997 Somatostatin in neuroblastoma and ganglioneuroma. Eur J Cancer 33:2084-2089
59. Robertson SC, Ackerman LL, Traynelis VC, Menzes AH 1997 Increased height in patients with medulloblastomas. Neurosurgery 41:561-565
60. Cordelier P, Esteve JP, Bousquet C, Delesque N, O'Carroll AM, Schally AV, Vaysse N, Susini C, Buscail L 1997 Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. Proc Natl Acad Sci USA 94:9343-9348
61. Caprara M, O'Dorisio MS, Albers AR, Frühwald MC, Fletcher WS 1998 Expression of somatostatin receptors in tumors derived from neural crest [abstract]. Dig Dis Sci 43:1905
62. Amacher AL, Torres QU, Rittenhouse S 1986 Congenital medulloblastoma: an inquiry into origins. Childs Nerv Syst 2:262-265
63. Trojanowski JQ, Tohyama T, Lee VMY 1992 Medulloblastomas and related primitive neuroectodermal brain tumors of childhood recapitulate molecular milestones in the maturation of neuroblasts. Mol Chem Neuropath 17:121-135
64. Gonzalez BJ, Leroux P, Basille M, Bodenant C, Vaudry H 1994 Somatostatin and pituitary adenylate cyclase-activating polypeptide (PACAP): two neuropeptides potentially involved in the development of the rat cerebellum. Ann Endocrinol 55:243-247
65. Gonzalez B, Leroux P, Lamacz M, Bodenant C, Balazs R, Vaudry H 1992 Somatostatin receptors are expressed by immature cerebellar granule cells: evidence for a direct inhibitory effect of somatostatin on neuroblast activity. Proc Natl Acad Sci USA 89:9627-9631
66. Gonzalez BJ, Leroux P, Bodenant C, Braquet P, Vaudry H 1990 Somatostatin receptors in the human cerebellum during development. J Neurochem 55:729-737
67. Gonzalez BJ, Leroux P, Laquerriere A, Coy DH, Bodenant C, Vaudry H 1998 Transient expression of somatostatin receptors in the rat cerebellum during development. Brain Res 468:154-157
68. Gilbertson RJ, Clifford SC, MacMeekin W, Wright C, Perry RH, Kelly P, Pearson ADJ 1998 Expression of the ErbB-neuregulin signaling network during cerebellar development: implications for the biology of medulloblastoma. Cancer Res 58:3932-3941
69. Piwko C, Thoss VS, Probst A, Hoyer D 1997 The elusive nature of cerebellar somatostatin receptors: studies in rat, monkey and human cerebellum. J Recept Signal Transduct Res 17:385-405
70. Paice JA, Penn RD, Kroin JS 1996 Intrathecal octreotide for relief of intractable nonmalignant pain: 5-year experience with two cases. Neurosurgery 38:203-207
71. Mollenholt P, Rawal N, Gordh T, Olsson Y 1994 Intrathecal and epidural somatostatin for patients with cancer. Anesthesiology 81:534-542
72. Lupoli G, Cascone E, Arlotta F, Vitale G, Celentano L, Salvatore M, Lombardi G 1996 Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon alpha-2b and octreotide. Cancer 78:1114-1118
73. Meropol NJ, Creaven PJ, Petrelli NJ 1995 Metastatic colorectal cancer: advances in biochemical modulation and new drug development. Semin Oncol 22:509-524
74. de Jong M, Breeman WA, Bakker WH, Kooij BWAP, Bernard BF, Hofland LJ, Visser TJ, Srinivasan A, Schmidt M, Erion JL, Bugaj JE, Macke HR, Krenning E 1998 Comparison of (111) In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. Cancer Res 58:437-441
75. 111In-pentetreotide: initial observations and future directions. Cancer J Sci Am 4:94-102
76. Dutour A, Kumar U, Panetta R, Ouafik L, Fina F, Sasi R, Patel YC 1998 Expression of somatostatin receptor subtypes in human brain tumors. Int J Cancer 76:620-627
77. Janson ET, Stridsberg M, Gobl A, Westlin JE, Oberg K 1998 Determination of somatostatin receptor subtype 2 in carcinoid subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin receptor subtype 2 antibodies. Cancer Res 58:2375-2378